So, here we showed that HIRA downregulation restricts CML cell proliferation and favor megakaryocyte differentiation due to an enrichment of histone variant H3.3 at the MKL1 and GATA2 promoter (Figure 5H). The gene discussed is HIRA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.